Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery (Q57183019)

From Wikidata

Jump to navigation Jump to search

No description defined

edit

Language	Label	Description	Also known as
English	Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery	No description defined

Statements

instance of

scholarly article

0 references

title

Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery (English)

0 references

main subject

nanoparticle

1 reference

based on heuristic

inferred from title

doxorubicin

1 reference

based on heuristic

inferred from title

author name string

Jaleh Varshosaz

series ordinal

1

0 references

Farshid Hassanzadeh

series ordinal

2

0 references

Amin Mardani

series ordinal

3

0 references

Mahboubeh Rostami

series ordinal

4

0 references

language of work or name

English

0 references

publication date

March 2015

0 references

published in

Pharmaceutical Development and Technology

0 references

volume

20

0 references

issue

2

0 references

page(s)

183-96

0 references

cites work

Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Drug penetration in solid tumours

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Further study of nebulisation chemotherapy, a new chemotherapeutic method in the treatment of lung carcinomas: fundamental and clinical

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Sigma ligands inhibit the growth of small cell lung cancer cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Optimization of the preparation process for human serum albumin (HSA) nanoparticles.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Metabolic stability of glutaraldehyde cross-linked peptide DNA condensates

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

5-Fluorouracil-loaded BSA nanoparticles: formulation optimization and in vitro release study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Albumin microspheres as a drug delivery system: relation among turbidity ratio, degree of cross-linking, and drug release.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Preparation and properties of inhalable nanocomposite particles: effects of the size, weight ratio of the primary nanoparticles in nanocomposite particles and temperature at a spray-dryer inlet upon properties of nanocomposite particles

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Characterization of a new inhalable thymopentin formulation.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Aerosolization behavior of carrier-free L-leucine coated salbutamol sulphate powders

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Spray dried mannitol carrier particles with tailored surface properties--the influence of carrier surface roughness and shape

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Stabilization of IgG1 in spray-dried powders for inhalation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Can low-dose combination products for inhalation be formulated in single crystalline particles?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10837450.2013.852576

retrieved

21 January 2018

Identifiers

DOI

10.3109/10837450.2013.852576

0 references

PubMed publication ID

24219091

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57183019&oldid=1531053418"